课题基金 / 基金详情

Development of Gene Therapy with Nanotechnology derived Intelligent Drug Deliver Systems

Development of Gene Therapy with Nanotechnology derived Intelligent Drug Deliver Systems
利用纳米技术衍生的智能药物输送系统开发基因治疗
批准号:
15390389
负责人:
YANAGIE Hironobu
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

YANAGIE Hironobu的其他基金

相关文献

中文摘要
翻译
我们开发了多离子复合物与DNA和多阳离子基因传递系统。选择聚乙烯亚胺进行多阳离子化,对转染癌细胞具有质子反应作用。聚乙烯-乙二醇结合羧基链也被用于包覆带阳离子的DNA/多阳离子配合物。为了提高转染效率,我们还检测了与流感病毒分析构建的pH敏感肽JTS-1。聚乙烯亚胺与DNA复合物的荧光素酶活性为1 × 10^9 IU/mg。用PEG-C包覆DNA/多离子复合物时,荧光素酶活性提高到3 × 10^9 IU/mg,这是由于PEG-C包覆后复合物的压实性和稳定性增强,从而提高了转染效率。将JTS-1加入到DNA/聚乙烯亚胺/乳糖结合的PEG-C复合物中,很容易逃脱溶酶体的裂解并将DNA转染到细胞质中,获得6 × 10^9 IU/mg的荧光素酶活性。肿瘤内注射β-gal DNA质粒/聚乙烯亚胺/乳糖结合PEG-C/JTS-1复合物对胃癌荷瘤小鼠模型转染β-gal基因的影响对奥沙利铂或顺铂敏感或耐药的癌细胞进行DNA微阵列分析发现,在奥沙利铂或顺铂耐药的癌细胞上,Tubrin特异性Chaperon E基因和CBP/ p300相互作用反激活子(CITED2)基因增加。
英文摘要
We develop polyion complex with DNA and polycation for gene delivery systems. Polyethyleneimine was selected for polycation that have protonsponde effect on transfection to cancer cells. Polyethylene-glycol binding carboxyl chain was also used for coating the cationic charged DNA/polycation complex. To increase the transfection efficacy, we also examined pH sensitive peptide, JTS-1 that constructed with analysis of Influenza virus. Polyethyleneimine and DNA complex showed 1 × 10^9 IU/mg luciferase activity. In case of coating the DNA/polyion complex with PEG-C, the luciferase activity was increase to 3 × 10^9 IU/mg, because of the compaction and incresent of stability with addition of PEG-C to complex, so the transfection efficacy was increased. When addition of JTS-1 to the DNA/polyethyleneimine/lactose-binding PEG-C complex, it is easily to escape the lysis of lysosome and transfect the DNA to cytoplasm, and 6 × 10^9 IU/mg luciferase activity was obtained. Increasing of transfection efficacy of β-gal gene by intratumor injection of β-gal DNA plasmid/Polyethyleneimine/lactose-binding PEG-C/JTS-1 complex on gastric cancer tumor bearing mice model.According to the analysis of DNA microarray with ancer cell lines that were sensitive or resistant to Oxaliplatin or Cisplatin, Tubrin specific Chaperon E gene and CBP/P300-interacting transactivator (CITED2) gene were increased on Oxaliplatin or Cisplatin resistant cancer cells.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
Kazuo Maruyama: "Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin."Pharmaceutical Research. 25. 275-279 (2003)
Kazuo Maruyama:“通过带有聚乙二醇偶联转铁蛋白的脂质体靶向大鼠缺血后脑内皮。”药物研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuo Maruyama: "Intracellular targeting of sodium mercaptoundecahydrododecaborate (BHS) to solid tumors by transferring-PEG liposomes, for boron neutron-capture therapy (BNCT)"J.Control.Release. (in press). (2004)
Kazuo Maruyama:“通过转移 PEG 脂质体将巯基十一氢十二硼酸钠 (BHS) 细胞内靶向实体瘤,用于硼中子捕获疗法 (BNCT)”J.Control.Release。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Intracellular targeting of sodium mercaptoundecahydrododecaborate(BSH)to solid tumors by transferring-PEG liposomes, for boron neutron-capture therapy (BNCT)
通过转移 PEG 脂质体将巯基十一氢十二硼酸钠 (BSH) 细胞内靶向实体瘤,用于硼中子俘获疗法 (BNCT)
DOI: --
发表时间: 2004
期刊: J.Control.Release Vol.98 No.2
影响因子: --
作者: [Hironobu Yanagie, Kazuo Maruyama]
通讯作者: Kazuo Maruyama
Intracellular targeting of sodium mercaptoundecathydrododecaborate(BHS)to solid tumors by transferring-PEG liposomes,for boron neutron-capture therapy (BNCT)
通过转移 PEG 脂质体将巯基十一氢十二硼酸钠 (BHS) 细胞内靶向实体瘤,用于硼中子俘获疗法 (BNCT)
DOI: --
发表时间: 2004
期刊: J.Control.Release 98,(2)
影响因子: --
作者: [Matsumoto S, et al., Yoden E, Matsumoto K. et al., Zamora CA, 松本慎一, Matsumoto K, Yamamoto T, Kuroki H, Kazuo Maruyama]
通讯作者: Kazuo Maruyama
共 16 条
    Development of Intelligent Gadorinium Neutron Capture Therapy asCancer Specific Atomic Suppression Therapy
    • 批准号:
      23659639
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      YANAGIE Hironobu
    • 依托单位:
    Molecular Targeting Therapy with Intelligent Drug Delivery System using Transporter
    • 批准号:
      13557104
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      2001
    • 负责人:
      YANAGIE Hironobu
    • 依托单位:
    Development of New Strategy of Boron Neutron Capture Therapy to Cancer Combined with Tumor Specific Gene Delivery
    International Collaboration for Application of Boron Neutron Capture Therapy to Intraoperative Irradiational Therapy